ORM Act

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $10,000

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - FAA Reauthorization Act of 2024 - Sections 367 and 368 - Emergency Medical Equipment on Passenger Aircraft (P.L. 118-63); Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $20,000

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - FAA Reauthorization Act of 2024 - Sections 367 and 368 - Emergency Medical Equipment on Passenger Aircraft (P.L. 118-63); Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $20,000

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - FAA Reauthorization Act of 2024 - Sections 367 and 368 - Emergency Medical Equipment on Passenger Aircraft (P.L. 118-63); Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $20,000

Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - FAA Reauthorization Act of 2024 - Sections 367 and 368 - Emergency Medical Equipment on Passenger Aircraft (P.L. 118-63); Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $20,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Further Consolidated Appropriations Act, 2024 - Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; Draft - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.

Client expense: Not reported · Firm income: $20,000